PL
USNA icon

Polianta Ltd’s Usana Health Sciences USNA Stock Holding History

Polianta Ltd’s Portfolio USNA Stock Details USNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-11,620
Closed -$669K – 97
2017
Q1 		$669K Hold
11,620
– – 0.4% 68
2016
Q4 		$711K Buy
+11,620
New +$757K 0.38% 75

Other funds holding USNA

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return
TA
Teachers Advisors New York $81.7B AUM 13.62% 1-Year Est. Return
JIM
Jupiter Investment Management London, United Kingdom $6.26B AUM 13.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Polianta Ltd's USNA Position: Q2 2017 in Review

Polianta Ltd sold out of Usana Health Sciences (USNA) in Q2 2017, closing a stake of 11,620 shares — an estimated $669K sold.

Polianta Ltd first reported a position in USNA in Q4 2016 and held it in 2 quarters. The position peaked at $711K in Q4 2016. 145 funds tracked by Wall St. Rank hold USNA as of Q2 2017.

  • Polianta Ltd reported no remaining Usana Health Sciences position as of Q2 2017 after selling out during the quarter.
  • Polianta Ltd sold 11,620 Usana Health Sciences shares in Q2 2017, an estimated $669K.
  • Polianta Ltd first reported a position in Usana Health Sciences in Q4 2016 and held it in 2 quarters.
  • Polianta Ltd's Usana Health Sciences position peaked at $711K in Q4 2016.
  • 145 funds tracked by Wall St. Rank held Usana Health Sciences as of Q2 2017.

Based on Polianta Ltd's 13F filing for Q2 2017, filed 5 Jul 2017.